401 related articles for article (PubMed ID: 3931643)
1. Effects of heavy metal cations, sulfhydryl reagents and other chemical agents on striatal D2 dopamine receptors.
Scheuhammer AM; Cherian MG
Biochem Pharmacol; 1985 Oct; 34(19):3405-13. PubMed ID: 3931643
[TBL] [Abstract][Full Text] [Related]
2. Effects of heavy metal cations and other sulfhydryl reagents on brain dopamine D1 receptors: evidence for involvement of a thiol group in the conformation of the active site.
Braestrup C; Andersen PH
J Neurochem; 1987 Jun; 48(6):1667-72. PubMed ID: 2952762
[TBL] [Abstract][Full Text] [Related]
3. Binding of 3H-spiperone and 3H-(-)-sulpiride to dopamine D2 receptors in rat striatal membranes: methodological considerations and demonstration of the identical nature of the binding sites for the two ligands.
Urwyler S; Coward D
Naunyn Schmiedebergs Arch Pharmacol; 1987 Feb; 335(2):115-22. PubMed ID: 2951601
[TBL] [Abstract][Full Text] [Related]
4. Effect of transition or heavy metals on [3H]haloperidol binding in rat striatal membranes in vitro.
Komulainen H; Anttonen P; Tuomisto J; Tuomisto L
Eur J Pharmacol; 1985 Aug; 114(2):113-9. PubMed ID: 2931291
[TBL] [Abstract][Full Text] [Related]
5. Ascorbate injury and EDTA (or manganese) protection of D2-dopamine receptors.
Chan B; Seeman P; Davis A; Madras BK
Eur J Pharmacol; 1982 Jun; 81(1):111-6. PubMed ID: 6126367
[TBL] [Abstract][Full Text] [Related]
6. Competitive inhibition of [3H]spiperone binding to D-2 dopamine receptors in striatal homogenates by organic calcium channel antagonists and polyvalent cations.
De Vries DJ; Beart PM
Eur J Pharmacol; 1984 Oct; 106(1):133-9. PubMed ID: 6241565
[TBL] [Abstract][Full Text] [Related]
7. Optimal conditions for [3H]apomorphine binding and anomalous equilibrium binding of [3H]apomorphine and [3H]spiperone to rat striatal membranes: involvement of surface phenomena versus multiple binding sites.
Leysen JE; Gommeren W
J Neurochem; 1981 Jan; 36(1):201-19. PubMed ID: 7463046
[TBL] [Abstract][Full Text] [Related]
8. Dopamine D2 receptors in the anterior pituitary: a single population without reciprocal antagonist/agonist states.
George SR; Watanabe M; Seeman P
J Neurochem; 1985 Apr; 44(4):1168-77. PubMed ID: 2579204
[TBL] [Abstract][Full Text] [Related]
9. Interaction of [3H]spiperone with rat striatal dopamine D-2 receptors: kinetic evidence for antagonist-induced formation of ternary complex.
Chatterjee TK; Scott CE; Vazquez DM; Bhatnagar RK
Mol Pharmacol; 1988 Apr; 33(4):402-13. PubMed ID: 3357484
[TBL] [Abstract][Full Text] [Related]
10. Mono- and divalent cations modulate the affinities of brain D1 and D2 receptors for dopamine by a mechanism independent of receptor coupling to guanyl nucleotide binding proteins.
Urwyler S
Naunyn Schmiedebergs Arch Pharmacol; 1989 Apr; 339(4):374-82. PubMed ID: 2500603
[TBL] [Abstract][Full Text] [Related]
11. Selective effects of thiol reagents on the binding sites for imipramine and neurotransmitter amines in the rat brain.
Biassoni R; Vaccari A
Br J Pharmacol; 1985 Jun; 85(2):447-56. PubMed ID: 2992663
[TBL] [Abstract][Full Text] [Related]
12. Specific [3H]SCH23390 binding to dopamine D1 receptors in cerebral cortex and neostriatum: role of disulfide and sulfhydryl groups.
Dewar KM; Reader TA
J Neurochem; 1989 Feb; 52(2):472-82. PubMed ID: 2463335
[TBL] [Abstract][Full Text] [Related]
13. Hepatic vasopressin receptor: differential effects of divalent cations, guanine nucleotides, and N-ethylmaleimide on agonist and antagonist interactions with the V1 subtype receptor.
Gopalakrishnan V; McNeill JR; Sulakhe PV; Triggle CR
Endocrinology; 1988 Aug; 123(2):922-31. PubMed ID: 2969327
[TBL] [Abstract][Full Text] [Related]
14. Specific [3H]raclopride binding to neostriatal dopamine D2 receptors: role of disulfide and sulfhydryl groups.
Reader TA; Molina-Holgado E; Lima L; Boulianne S; Dewar KM
Neurochem Res; 1992 Aug; 17(8):749-59. PubMed ID: 1379349
[TBL] [Abstract][Full Text] [Related]
15. Effect of CH3HgCl and several transition metals on the dopamine neuronal carrier; peculiar behaviour of Zn2+.
Bonnet JJ; Benmansour S; Amejdki-Chab N; Costentin J
Eur J Pharmacol; 1994 Jan; 266(1):87-97. PubMed ID: 8137886
[TBL] [Abstract][Full Text] [Related]
16. Effect of cadmium, mercury and copper on partially purified hepatic flavokinase of rat.
Bandyopadhyay D; Chatterjee AK; Datta AG
Mol Cell Biochem; 1997 Feb; 167(1-2):73-80. PubMed ID: 9059983
[TBL] [Abstract][Full Text] [Related]
17. Effects of inorganic mercury on [3H]dopamine release and calcium homeostasis in rat striatal synaptosomes.
Hare MF; Rezazadeh SM; Cooper GP; Minnema DJ; Michaelson IA
Toxicol Appl Pharmacol; 1990 Feb; 102(2):316-30. PubMed ID: 2300972
[TBL] [Abstract][Full Text] [Related]
18. Regulation of ligand binding to pituitary D-2 dopaminergic receptors. Effects of divalent cations and functional group modification.
Sibley DR; Creese I
J Biol Chem; 1983 Apr; 258(8):4957-65. PubMed ID: 6833284
[TBL] [Abstract][Full Text] [Related]
19. Chemical modification reveals involvement of tyrosine in ligand binding to dopamine D1 and D2 receptors.
Srivastava LK; Mishra RK
Biochem Int; 1990; 21(4):705-14. PubMed ID: 2241996
[TBL] [Abstract][Full Text] [Related]
20. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
Thomas KL; Rose S; Jenner P; Marsden CD
Biochem Pharmacol; 1992 Jul; 44(1):83-91. PubMed ID: 1321631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
